• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,267.34 -508.40
( -0.68%)
Global Indices
Nasdaq
51,069.65 379.68
(0.75%)
Dow Jones
7,605.10 20.47
(0.27%)
Hang Seng
67,130.34 800.84
(1.21%)
Nikkei 225
10,420.12 -5.84
(-0.06%)
Forex
USD-INR
95.93 0.16
(0.16%)
EUR-INR
111.54 0.10
(0.09%)
GBP-INR
128.71 -0.01
(-0.01%)
JPY-INR
0.60 0.00
(0.17%)

EQUITY - MARKET SCREENER

Rossari Biotech Ltd
Industry :  Chemicals
BSE Code
ISIN Demat
Book Value()
543213
INE02A801020
219.9788403
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ROSSARI
20.13
2875.1
EPS(TTM)
Face Value()
Div & Yield %
25.79
2
0.1
 

Maruti Suzuki India posts 35% surge in May sales
Jun 01,2026

Total domestic sales (including passenger vehicles, light commercial vehicles and OEM supplies) increased 34.87% to 2,00,774 units in May 2026, compared with 1,48,858 units in May 2025.

Total export sales stood at 41,914 units in May 2026, up 34.25% compared with 31,219 units in May 2025.

Maruti Suzuki India is engaged in the manufacture, purchase, and sale of motor vehicles, components, and spare parts (automobiles).

On a standalone basis, net profit declined 6.9% YoY to Rs 3,590.5 crore in Q4 FY26 from Rs 3,857.3 crore in Q4 FY25. Revenue from operations rose 28.9% YoY to Rs 50,078.7 crore in Q4 FY26 compared with Rs 38,839.1 crore a year ago.

Shares of Maruti Suzuki India fell 1.07% to Rs 12,980 on the BSE.